Anuradha Kumari
Overview
Explore the profile of Anuradha Kumari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumari A, Akhtar M, Shah R, Tanveer M
Neural Netw
. 2024 Nov;
181:106767.
PMID: 39488110
Support vector machine (SVM) is one of the most studied paradigms in the realm of machine learning for classification and regression problems. It relies on vectorized input data. However, a...
2.
Jin F, Gridley J, Kumari A, Saeidi A, Holland B, Elrod E, et al.
J Hepatol
. 2024 Oct;
PMID: 39423870
Background & Aims: The most recent T cell-based vaccine against HCV tested in humans failed to swing the pendulum from chronicity to resolution, despite eliciting cellular responses in most individuals....
3.
Kumari A, K G R, Sudhakaran V A, Warrier A, Singh N
Indian J Microbiol
. 2024 Jul;
64(2):376-388.
PMID: 39010994
Prebiotics play a pivotal role in fostering probiotics, essential contributors to the creation and maintenance of a conducive environment for beneficial microbiota within the human gut. To qualify as a...
4.
Choudhary M, Ahmad A, Kumari A, Prasad D, Kumar N
Cureus
. 2024 May;
16(4):e58982.
PMID: 38800254
Introduction: When acute kidney damage occurs during pregnancy, it poses a difficult clinical problem. One of the main causes of maternal and fetal morbidity and death is pregnancy-related acute kidney...
5.
Gridley J, Holland B, Salinas E, Trivedi S, Dravid P, Elrod E, et al.
Hepatology
. 2024 Jan;
80(4):937-950.
PMID: 38214558
Background And Aims: Evidence assessing the role of B cells and their antibodies, or lack thereof, in the spontaneous resolution of acute HCV infection is conflicting. Utilization of a strictly...
6.
Giri P, Batra P, Kumari A, Hura N, Adhikary R, Acharya A, et al.
Bioorg Med Chem
. 2023 Oct;
95:117489.
PMID: 37816266
In this study of creating new molecules from clinical trial agents, an approach of Combretastatin structural modulation with the installation of NP-privileged motifs was considered, and a series of trimethoxyphenyl-2-aminoimidazole...
7.
Dravid P, Murthy S, Attia Z, Cassady C, Chandra R, Trivedi S, et al.
PLoS Pathog
. 2023 Oct;
19(10):e1011697.
PMID: 37812637
Immune correlates of hepatitis C virus (HCV) clearance and control remain poorly defined due to the lack of an informative animal model. We recently described acute and chronic rodent HCV-like...
8.
Thapa M, Kumari A, Chin C, Choby J, Jin F, Bogati B, et al.
bioRxiv
. 2023 Sep;
PMID: 37693595
The gut-brain axis, a bidirectional signaling network between the intestine and the central nervous system, is crucial to the regulation of host physiology and inflammation. Recent advances suggest a strong...
9.
Batra P, Kumari A, Liao V, Hibbs D, Groundwater P, Panda D
J Biochem
. 2023 Apr;
174(2):143-164.
PMID: 37039772
Here, we show that 3,5-bis[(1E)-2-(2,6-dichlorophenyl)ethenyl]-1H-pyrazole 2l depolymerizes microtubules and reduces the number of growing tips of microtubules. The fluorescence recovery after photobleaching experiment in live MCF-7 cells showed that pyrazole...
10.
Kumari A, Prassanawar S, Panda D
ACS Chem Neurosci
. 2022 Dec;
14(1):19-34.
PMID: 36541944
Indibulin, a microtubule-depolymerizing agent, produces minimal neurotoxicity in animals. It is also less cytotoxic toward differentiated neuronal cells than undifferentiated cells. We found that the levels of β-III tubulin, acetylated...